Gene · 2925
Papers2,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Novel Achievements in Oncological Metabolic Radio-Therapy: Isotope Technologies, Targeted Theranostics, Translational Oncology Research. | Med Sci (Basel) | 2025 | 40843729 | PubTator, text mining | PubMed |
| GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy. | Semin Nucl Med | 2025 | 40796452 | PubTator, text mining | PubMed |
| A molecular and spinal circuit basis for the functional segregation of itch and pain. | bioRxiv | 2025 | 40766363 | PubTator, text mining | PubMed |
| Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells. | EJNMMI Res | 2025 | 40751101 | PubTator, text mining | PubMed |
| RM2 and DB15 analogues bearing [177Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study. | EJNMMI Radiopharm Chem | 2025 | 40745236 | PubTator, text mining | PubMed |
| Human dose estimation of a novel SPECT imaging agent using animal experimental data and Monte Carlo simulation. | Radiat Environ Biophys | 2025 | 40736585 | PubTator, text mining | PubMed |
| Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [99mTc]Tc-PSMA-I&S and [111In]In-RM2. | Pharmaceuticals (Basel) | 2025 | 40732291 | PubTator, text mining | PubMed |
| A Call for Common Sense in the Use of Molecular Imaging. | J Nucl Med | 2025 | 40675755 | PubTator, text mining | PubMed |
| Publisher Correction: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin. | Nature | 2025 | 40659787 | PubTator, text mining | PubMed |
| Cataract-Causing Mutant R188C of βB2 Crystallin With Low Structural Stability is Sensitive to Environmental Stresses and Prone to Aggregates Formation. | Exploration (Beijing) | 2025 | 40585754 | PubTator, text mining | PubMed |
| The additive value of 68Ga-RM26 PET/CT to 68Ga-PSMA-617 PET/CT in assessing Post-treatment outcomes of ARSIs in mCRPC patients. | Eur J Nucl Med Mol Imaging | 2025 | 40518457 | PubTator, text mining | PubMed |
| Comparative evaluation of radiolabeled bombesin analogs [177Lu]Lu-AMBA and [177Lu]Lu-RM2 for targeting GRPR in glioblastoma model. | Nucl Med Biol | 2025 | 40516177 | PubTator, text mining | PubMed |
| Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin. | Nature | 2025 | 40500450 | PubTator, text mining | PubMed |
| GRPR-targeted gold nanoparticles as selective radiotherapy enhancers in glioblastoma. | Phys Med Biol | 2025 | 40480252 | PubTator, text mining | PubMed |
| NOTA and NODAGA Radionuclide Complexing Agents: Versatile Approaches for Advancements in Radiochemistry. | Molecules | 2025 | 40430268 | PubTator, text mining | PubMed |
| Molecular imaging of neuroendocrine tumors: Current applications and future trends. | Diagn Interv Imaging | 2025 | 40404554 | PubTator, text mining | PubMed |
| Development of Novel Gastrin-Releasing Peptide Receptor-Targeted Radioligand with Albumin Binder to Improve Accumulation in Tumor. | ACS Med Chem Lett | 2025 | 40365411 | PubTator, text mining | PubMed |
| A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry. | J Nucl Med | 2025 | 40341094 | PubTator, text mining | PubMed |
| Comprehensive transcriptome analysis and lncRNA-miRNA-mRNA establishment of schizophrenia based on induced pluripotent stem cells. | Schizophr Res | 2025 | 40311511 | PubTator, text mining | PubMed |
| First-in-Human Serum Stability Studies of [177Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy. | J Nucl Med | 2025 | 40306971 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2925/papers?page=4